{"id":"W1905645497","doi":"10.1183/13993003/erj.44.suppl_58.2910","title":"Late-breaking abstract: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting the allergen-induced early asthmatic response","year":2014,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Alberta; Université Laval; University of Saskatchewan; University of Calgary; Royal University Hospital; McMaster University","funders":"","keywords":"Omalizumab; Placebo; Medicine; Tolerability; Asthma; Provocation test; Allergen; Immunoglobulin E; Pharmacology; Allergy; Immunology; Internal medicine; Adverse effect; Antibody; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001367934,0.001003373,0.002462964,0.0002908269,0.0002679908,0.0008313595,0.001099681,0.001536953,0.008014481],"category_scores_gemma":[0.0008180747,0.0004547072,0.001421117,0.0001971221,0.0005265423,0.0005763746,0.0002593481,0.002161128,0.001288418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005761832,"about_ca_system_score_gemma":0.0006245804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004566066,"about_ca_topic_score_gemma":0.0008232088,"domain_scores_codex":[0.9994661,0.0002349878,0.00005891335,0.00009313576,0.00007013061,0.00007671024],"domain_scores_gemma":[0.99928,0.0001653553,0.0002463322,0.00005857848,0.00006194299,0.0001877091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8496429,0.009983784,0.0006242201,0.001539383,0.0009611768,0.00006164116,0.00003680084,0.0003111307,0.06352575,0.0001301682,0.001484783,0.0716983],"study_design_scores_gemma":[0.5052445,0.4554027,0.009532372,0.0001694557,0.001370863,0.0001959137,0.00003018598,0.0006420773,0.0239061,0.0001984981,0.003266838,0.00004050834],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.97501,0.01619873,0.001458456,0.001021256,0.0007896454,0.001794607,0.001653827,0.0002268497,0.00184653],"genre_scores_gemma":[0.9855532,0.003817274,0.001908291,0.00106221,0.0008382091,0.0008591585,0.00116706,0.00002857066,0.004766119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008014481,"threshold_uncertainty_score":0.02681106,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02807256668151701,"score_gpt":0.2739280922742894,"score_spread":0.2458555255927724,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}